Cadrenal Therapeutics (CVKD) Stock Chart & Stock Price History $12.29 -0.15 (-1.21%) Closing price 07/3/2025 02:45 PM EasternExtended Trading$12.64 +0.35 (+2.85%) As of 07/3/2025 04:33 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Cadrenal Therapeutics Stock Price Performance The Cadrenal Therapeutics (CVKD) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 15.18%. In the past month, the stock has decreased 20.66%, reflecting recent market activity. As of the latest close, Cadrenal Therapeutics traded at $12.29 with a market cap of $24.21 million and volume of 20,178 shares. Receive CVKD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+17.72%1 Month Performance-20.66%3 Month Performance-24.00%Year-To-Date Performance-15.18% CVKD Stock Chart for Friday, July, 4, 2025 CVKD Chart by TradingView Cadrenal Therapeutics Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/03/2025$12.44$12.29-1.21%$13.24$12.0420,178 shs$24.21 million07/02/2025$11.67$12.44+6.60%$12.68$11.2147,780 shs$24.51 million07/01/2025$12.05$11.67-3.15%$12.32$11.0037,218 shs$22.99 million06/30/2025$10.44$12.05+15.42%$13.71$11.16179,701 shs$23.74 million06/27/2025$10.28$10.44+1.56%$10.84$10.1128,710 shs$20.57 million06/26/2025$10.35$10.28-0.68%$10.62$10.0222,440 shs$20.25 million06/25/2025$11.24$10.35-7.92%$11.09$10.2421,602 shs$20.36 million06/24/2025$11.44$11.24-1.75%$11.44$10.0045,902 shs$22.14 million06/23/2025$12.35$11.44-7.37%$13.30$11.0023,965 shs$22.54 million06/20/2025$13.39$12.35-7.77%$13.23$12.2715,057 shs$24.29 million Get the Latest News and Ratings for CVKD and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 06/19/2025$13.39$13.39$13.49$13.118,504 shs$26.38 million06/18/2025$13.13$13.39+1.98%$13.49$13.118,504 shs$26.38 million06/17/2025$13.70$13.13-4.16%$13.70$13.1215,015 shs$25.83 million06/16/2025$13.86$13.70-1.15%$13.99$13.4515,935 shs$26.95 million06/13/2025$14.99$13.86-7.54%$14.69$13.6719,706 shs$27.26 million06/12/2025$15.00$14.99-0.07%$15.99$14.5138,419 shs$29.49 million06/11/2025$15.00$15.00$15.00$14.6312,715 shs$29.51 million06/10/2025$15.00$15.00$15.32$14.5723,792 shs$29.51 million06/09/2025$15.10$15.00-0.66%$15.50$14.8723,243 shs$29.51 million06/06/2025$14.61$15.10+3.35%$15.50$14.9023,719 shs$29.70 million06/05/2025$15.49$14.61-5.68%$15.68$14.4920,390 shs$28.74 million06/04/2025$13.69$15.49+13.15%$15.87$13.7066,055 shs$30.47 million06/03/2025$13.54$13.69+1.11%$13.69$13.2517,810 shs$26.93 million Related Companies FBRX Stock Chart CLLS Stock Chart CLYM Stock Chart CABA Stock Chart MCRB Stock Chart TCRX Stock Chart VNRX Stock Chart SRZN Stock Chart EPIX Stock Chart PLRX Stock Chart Receive CVKD Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Cadrenal Therapeutics and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CVKD) was last updated on 7/4/2025 by MarketBeat.com Staff From Our PartnersElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredHave you heard of “E.I.”?Inside Expert: New "E.I." Tech Could Be Poised For 200,000% Growth Meta, Apple, and even NASA are rushing t...Behind the Markets | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredGold: Now legal tender in many statesThe perfect gold play right now? (currently under $10) Everything in the news now lines up perfectly for an...Stansberry Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cadrenal Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Cadrenal Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
